These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 21470181)

  • 21. Present and future in vitro approaches for drug metabolism.
    Ekins S; Ring BJ; Grace J; McRobie-Belle DJ; Wrighton SA
    J Pharmacol Toxicol Methods; 2000; 44(1):313-24. PubMed ID: 11274898
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High throughput ADME screening: practical considerations, impact on the portfolio and enabler of in silico ADME models.
    Hop CE; Cole MJ; Davidson RE; Duignan DB; Federico J; Janiszewski JS; Jenkins K; Krueger S; Lebowitz R; Liston TE; Mitchell W; Snyder M; Steyn SJ; Soglia JR; Taylor C; Troutman MD; Umland J; West M; Whalen KM; Zelesky V; Zhao SX
    Curr Drug Metab; 2008 Nov; 9(9):847-53. PubMed ID: 18991580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug permeation in biomembranes: in vitro and in silico prediction and influence of physicochemical properties.
    Mälkiä A; Murtomäki L; Urtti A; Kontturi K
    Eur J Pharm Sci; 2004 Sep; 23(1):13-47. PubMed ID: 15324921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro ADME profiling using high-throughput rapidfire mass spectrometry: cytochrome p450 inhibition and metabolic stability assays.
    Wu X; Wang J; Tan L; Bui J; Gjerstad E; McMillan K; Zhang W
    J Biomol Screen; 2012 Jul; 17(6):761-72. PubMed ID: 22460176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In silico prediction of drug metabolism by P450.
    Andrade CH; Silva DC; Braga RC
    Curr Drug Metab; 2014; 15(5):514-25. PubMed ID: 25204822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. De-risking drug discovery with ADDME -- avoiding drug development mistakes early.
    Tsaioun K; Jacewicz M
    Altern Lab Anim; 2009 Sep; 37 Suppl 1():47-55. PubMed ID: 19807206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug metabolism and pharmacokinetics in drug discovery.
    Roberts SA
    Curr Opin Drug Discov Devel; 2003 Jan; 6(1):66-80. PubMed ID: 12613278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improving early drug discovery through ADME modelling: an overview.
    Wishart DS
    Drugs R D; 2007; 8(6):349-62. PubMed ID: 17963426
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In Silico and Ex silico ADME approaches for drug discovery.
    Darvas F; Keseru G; Papp A; Dormán G; Urge L; Krajcsi P
    Curr Top Med Chem; 2002 Dec; 2(12):1287-304. PubMed ID: 12470281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Review of current chemoinformatic tools for modeling important aspects of CYPs-mediated drug metabolism. Integrating metabolism data with other biological profiles to enhance drug discovery.
    Speck-Planche A; Cordeiro MN
    Curr Drug Metab; 2014; 15(4):429-40. PubMed ID: 24909424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Considerations and recent advances in QSAR models for cytochrome P450-mediated drug metabolism prediction.
    Li H; Sun J; Fan X; Sui X; Zhang L; Wang Y; He Z
    J Comput Aided Mol Des; 2008 Nov; 22(11):843-55. PubMed ID: 18574695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of predictive metabolism and toxicity modeling in drug discovery--a summary of some recent advancements.
    Wilson AG; White AC; Mueller RA
    Curr Opin Drug Discov Devel; 2003 Jan; 6(1):123-8. PubMed ID: 12613284
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Application of in silico approaches to predicting drug--drug interactions.
    Ekins S; Wrighton SA
    J Pharmacol Toxicol Methods; 2001; 45(1):65-9. PubMed ID: 11489666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Virtual screening for cytochromes p450: successes of machine learning filters.
    Burton J; Ijjaali I; Petitet F; Michel A; Vercauteren DP
    Comb Chem High Throughput Screen; 2009 May; 12(4):369-82. PubMed ID: 19442071
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Approaches for high-throughput pharmacokinetic screening of low-molecular-weight drug candidates.
    Fontana S
    Expert Opin Drug Metab Toxicol; 2014 Feb; 10(2):139-42. PubMed ID: 24329157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytochrome P450s and other enzymes in drug metabolism and toxicity.
    Guengerich FP
    AAPS J; 2006 Mar; 8(1):E101-11. PubMed ID: 16584116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MetaSite: understanding metabolism in human cytochromes from the perspective of the chemist.
    Cruciani G; Carosati E; De Boeck B; Ethirajulu K; Mackie C; Howe T; Vianello R
    J Med Chem; 2005 Nov; 48(22):6970-9. PubMed ID: 16250655
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SOMEViz: a web service for site of metabolism estimating and visualizing.
    Shen Q; Zheng M; Lu J; Luo C; Zhu W; Chen K; Luo X; Jiang H
    Protein Pept Lett; 2012 Sep; 19(9):905-9. PubMed ID: 22894162
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of Pfizer compounds in EPA's ToxCast chemicals-assay space.
    Shah F; Greene N
    Chem Res Toxicol; 2014 Jan; 27(1):86-98. PubMed ID: 24328225
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of cytochrome P450 mediated metabolism.
    Olsen L; Oostenbrink C; Jørgensen FS
    Adv Drug Deliv Rev; 2015 Jun; 86():61-71. PubMed ID: 25958010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.